News Home

Is Rite Aid Corporation (RAD) a Winner in the Pharmaceutical Retailers Industry?

Thursday, August 18, 2022 12:43 PM | InvestorsObserver Analysts
Is Rite Aid Corporation (RAD) a Winner in the Pharmaceutical Retailers Industry?

The 57 rating InvestorsObserver gives to Rite Aid Corporation (RAD) stock puts it near the top of the Pharmaceutical Retailers industry. In addition to scoring higher than 100 percent of stocks in the Pharmaceutical Retailers industry, RAD’s 57 overall rating means the stock scores better than 57 percent of all stocks.

Overall Score - 57
RAD has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on RAD!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 57 means the stock is more attractive than 57 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Rite Aid Corporation Stock Today?

Rite Aid Corporation (RAD) stock is trading at $9.01 as of 12:35 PM on Thursday, Aug 18, a loss of -$1.50, or -14.27% from the previous closing price of $10.51. The stock has traded between $9.01 and $10.55 so far today. Volume today is 1,991,573 compared to average volume of 2,055,166. Click Here to get the full Stock Report for Rite Aid Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App